Myocardial infarction after rituximab treatment for rheumatoid arthritis: Is there a link?
- PMID: 23565629
- DOI: 10.2174/13816128113199990386
Myocardial infarction after rituximab treatment for rheumatoid arthritis: Is there a link?
Abstract
Rituximab is an anti-CD20 monoclonal antibody often used in the treatment of rheumatoid arthritis (RA). Infusion reactions sometimes develop following rituximab administration. Delayed complications are rare. Acute coronary syndromes are listed as sideeffects of rituximab therapy. We report two cases of acute myocardial infarction following rituximab therapy for RA and review the literature regarding cardiac events in patients treated with rituximab. We would like to raise awareness of this possible complication in patients treated with rituximab.
Similar articles
-
Rituximab.Indian Pediatr. 2011 Aug;48(8):627-32. doi: 10.1007/s13312-011-0098-6. Indian Pediatr. 2011. PMID: 21918268 Review.
-
Use of intravenous immunoglobulin to treat chronic bilateral otomastoiditis in the setting of rituximab induced hypogammaglobulinemia.Am J Otolaryngol. 2012 Sep-Oct;33(5):619-22. doi: 10.1016/j.amjoto.2012.01.006. Epub 2012 Feb 21. Am J Otolaryngol. 2012. PMID: 22361345
-
Induced psoriasis after rituximab therapy for rheumatoid arthritis: a case report and review of the literature.Rheumatol Int. 2013 Nov;33(11):2927-30. doi: 10.1007/s00296-012-2581-3. Epub 2012 Nov 8. Rheumatol Int. 2013. PMID: 23135613 Review.
-
Rheumatoid arthritis: When should we use rituximab to treat RA?Nat Rev Rheumatol. 2011 May 31;7(7):379-80. doi: 10.1038/nrrheum.2011.79. Nat Rev Rheumatol. 2011. PMID: 21629243 No abstract available.
-
Knee tuberculosis under rituximab therapy for rheumatoid arthritis.Joint Bone Spine. 2013 Jul;80(4):435-6. doi: 10.1016/j.jbspin.2012.10.018. Epub 2012 Dec 11. Joint Bone Spine. 2013. PMID: 23238006 No abstract available.
Cited by
-
Acute myocardial infarction after first dose of rituximab infusion.Turk J Haematol. 2014 Mar;31(1):95-6. doi: 10.4274/Tjh.2013.0247. Epub 2014 Mar 5. Turk J Haematol. 2014. PMID: 24764738 Free PMC article. No abstract available.
-
Effect of Biologics on Cardiovascular Inflammation: Mechanistic Insights and Risk Reduction.J Inflamm Res. 2021 May 14;14:1915-1931. doi: 10.2147/JIR.S282691. eCollection 2021. J Inflamm Res. 2021. PMID: 34017189 Free PMC article. Review.
-
Cardiac involvement in primary systemic vasculitis and potential drug therapies to reduce cardiovascular risk.Rheumatol Int. 2017 Jan;37(1):151-167. doi: 10.1007/s00296-016-3435-1. Epub 2016 Feb 17. Rheumatol Int. 2017. PMID: 26886388 Review.
-
Adverse cardiac events to monoclonal antibodies used for cancer therapy: The risk of Kounis syndrome.Oncoimmunology. 2014 Feb 14;3:e27987. doi: 10.4161/onci.27987. eCollection 2014. Oncoimmunology. 2014. PMID: 25340003 Free PMC article.
-
Cardiovascular risk and the use of biologic agents in rheumatoid arthritis.Curr Rheumatol Rep. 2014 Nov;16(11):459. doi: 10.1007/s11926-014-0459-y. Curr Rheumatol Rep. 2014. PMID: 25315196 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical